FN1 and chronic myelogenous leukemia, BCR-ABL1 positive: Furthermore, patients with relapsed CML showed a decrease in FN1 levels in the peripheral blood at the time of diagnosis (median [IQR 25–75]: 2.1 × 10−6 [5.6 × 10−7 – 2.4 × 10−4], p = 0.003), as well as during the loss of MMR compared to the CML cohort 1 (median [IQR 25–75]: 1.4 × 10−5 [3.8 × 10−6 – 9.2 × 10−5], p = 0.003, Figure 7).